Everence Capital Management Inc. Holds Stake in UnitedHealth Group Inc (UNH)

Everence Capital Management Inc. continued to hold its position in UnitedHealth Group Inc (NYSE:UNH) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,852 shares of the healthcare conglomerate’s stock at the end of the first quarter. UnitedHealth Group accounts for 0.9% of Everence Capital Management Inc.’s investment portfolio, making the stock its 23rd largest position. Everence Capital Management Inc.’s holdings in UnitedHealth Group were worth $3,420,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Scott & Selber Inc. raised its position in UnitedHealth Group by 0.5% in the third quarter. Scott & Selber Inc. now owns 25,274 shares of the healthcare conglomerate’s stock worth $3,538,000 after buying an additional 128 shares during the last quarter. UMB Bank N A MO raised its position in UnitedHealth Group by 3.1% in the third quarter. UMB Bank N A MO now owns 171,603 shares of the healthcare conglomerate’s stock worth $24,024,000 after buying an additional 5,234 shares during the last quarter. Enterprise Financial Services Corp raised its stake in UnitedHealth Group by 3.0% in the third quarter. Enterprise Financial Services Corp now owns 1,847 shares of the healthcare conglomerate’s stock valued at $259,000 after buying an additional 54 shares in the last quarter. World Asset Management Inc raised its stake in UnitedHealth Group by 2.1% in the third quarter. World Asset Management Inc now owns 99,467 shares of the healthcare conglomerate’s stock valued at $13,925,000 after buying an additional 2,018 shares in the last quarter. Finally, Rothschild Asset Management Inc. raised its stake in UnitedHealth Group by 10,170.5% in the third quarter. Rothschild Asset Management Inc. now owns 287,574 shares of the healthcare conglomerate’s stock valued at $40,260,000 after buying an additional 284,774 shares in the last quarter. Institutional investors and hedge funds own 86.67% of the company’s stock.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group Inc (NYSE:UNH) traded up 0.66% during mid-day trading on Friday, hitting $172.59. 3,877,349 shares of the stock were exchanged. UnitedHealth Group Inc has a 12-month low of $130.01 and a 12-month high of $176.14. The stock’s 50 day moving average price is $170.26 and its 200-day moving average price is $162.54. The stock has a market capitalization of $166.32 billion, a P/E ratio of 22.09 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.17 by $0.20. The business had revenue of $48.72 billion during the quarter, compared to analyst estimates of $48.21 billion. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. UnitedHealth Group’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.81 earnings per share. On average, equities research analysts expect that UnitedHealth Group Inc will post $9.79 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://www.chaffeybreeze.com/2017/05/20/everence-capital-management-inc-has-3420000-position-in-unitedhealth-group-inc-unh-updated.html.

UNH has been the topic of several research analyst reports. Deutsche Bank AG initiated coverage on shares of UnitedHealth Group in a research report on Wednesday, April 5th. They issued a “buy” rating and a $183.00 price target on the stock. Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price target on the stock in a research report on Wednesday, April 5th. Cantor Fitzgerald restated an “overweight” rating and issued a $200.00 price target on shares of UnitedHealth Group in a research report on Thursday, April 6th. Mizuho lifted their target price on shares of UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, April 18th. Finally, Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research report on Tuesday, March 21st. Two investment analysts have rated the stock with a hold rating and twenty-two have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $182.65.

In related news, Director Michele J. Hooper sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, March 16th. The stock was sold at an average price of $170.89, for a total transaction of $2,563,350.00. Following the completion of the transaction, the director now owns 35,941 shares in the company, valued at $6,141,957.49. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Kenneth Irwin Shine sold 838 shares of the company’s stock in a transaction that occurred on Wednesday, April 19th. The shares were sold at an average price of $169.12, for a total value of $141,722.56. Following the transaction, the director now owns 28,528 shares of the company’s stock, valued at approximately $4,824,655.36. The disclosure for this sale can be found here. Insiders sold 40,148 shares of company stock valued at $6,806,849 in the last quarter. Corporate insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

12 Month Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply